High Cardiovascular Risk
High cardiovascular risk refers to an increased likelihood of experiencing heart-related issues, often due to factors like a history of cardiovascular disease or genetic conditions such as familial hypercholesterolemia.
Statin Intolerance: Personalized Treatment Study
We are exploring whether personalized treatment plans can help people who struggle with statin medications. The goal is to improve their cholesterol management while minimizing side effects.
6-12 months≤5 visitsMonitoring phase (IV)Cost ReimbursementPartially RemoteInvestigational MedicinesOralCardiologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Statin Intolerance
Statin intolerance is a condition where patients experience adverse effects from statin medications, which are commonly prescribed to lower cholesterol levels and reduce cardiovascular risk.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Have you previously taken two or more statins and stopped due to side effects?
- Are you currently pregnant or breastfeeding?
- Do you have a history of severe muscle problems or pain?
- Have you had a major heart event in the past 3 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Rosuvastatin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Meander Medisch Centrum
Internal Medicine
Amersfoort, Netherlands
Rijnstate Ziekenhuis Stichting
Internal Medicine
Arnhem, Netherlands
Maasstad Ziekenhuis Stichting
Internal Medicine
Barendrecht, Netherlands
Sponsor: Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.